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Abstract
Objective: Enterocutaneous fistula is an unpleasant and troublesome complication of abdominal operations. The 
objective was to review the outcome of treatment of patients treated for enterocutaneous fistula. 
Materials and Methods: This is a retrospective study of 82 teenage and adult patients, who suffered from 
enterocutaneous fistula, seen over an 11 year period, in the University of Nigeria Teaching Hospital, Enugu. Patients’ 
charts were reviewed for biodata, etiology of the fistula, volume of the fistula output, and result of treatment. Majority of 
the fistulas occurred after abdominal operations; many by general practitioners. After treatment for correction of fluid 
and electrolyte deficits, they were all tried on conservative therapy with enteral nutritional support as the main stay of 
management. Those, whose fistulas did not close, underwent surgical treatment. Total parenteral nutrition, octreotide, 
fibrin glue, and wound vacuum assisted closure (VAC) were not used for treating these patients. 
Results: Spontaneous healing of fistulas occurred in 26 patients (31.7%), whereas 42 patients out of 50 (84%) healed 
after definitive operation. Fourteen patients (17%) in this study, died. 
Conclusion: Proper management of fluid and electrolyte imbalances, enteral nutritional support, control of sepsis and 
correctly timed surgical therapy, resulted in this good healing rate and acceptable mortality, without the use of parenteral 
nutrition, biologic fibrin glue injection or VAC. Suggestions are offered about steps that may help in eradicating some 
of these enterocutaneous fistulas.
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Introduction
Enterocutaneous fistula is an unpleasant and frightening 
complication of operations on the digestive tract. It can 
also be caused by trauma, malignancy, or inflammatory 
bowel disease.[1,2] The treatment can be tasking on 
account of weight loss from malnutrition, which leads 
to impairment of many components of the immune 
system; fluid and electrolyte disturbances, sepsis, 
and skin damage. Hospital stay for patients with this 
disorder is often long and uncomfortable. The principles 
of treatment for favorable outcome therefore include 
patient resuscitation, early control of sepsis, adequate 
nutritional support, skin protection, and care.[3-5] By 
applying these principles, mortality rates have improved 
significantly, falling from 65% to as low as 20%; rates of 
less than 10% are rare.[2,6,7] Treatment of these patients in 
the developing countries is even more challenging than 
what is obtained in the developed countries, where total 
parenteral nutrition is well developed, and technical as 
well as pharmacological agents for manipulating fistula 
effluents are easily available. This study was undertaken 
to evaluate our management and outcome, without the 
use of total parenteral nutrition, biologic fibrin glue 
injection, or wound vacuum assisted closure (VAC), 
which are easily available in advanced countries. It is 
a retrospective study of 82 teenage and adult patients 
seen over an 11 year period in the University of Nigeria 
Teaching Hospital, Enugu, a major tertiary referral centre 
in south-eastern Nigeria.
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Materials and Methods
The charts of all patients with intestinal fistula seen at the 
University of Nigeria Teaching, Enugu, from 1998 to 2009 
were analyzed. Patients with esophageal, gastric, enterovesical, 
and enterovaginal fistulas were excluded from the study. Each 
chart was reviewed for the following information; age and 
sex of the patients, origin of the fistula, volume of the fistula 
output, type of therapy received by the patient (i.e., operative 
or non-operative), and treatment outcome.
Patients were managed in a standard manner by different 
surgical units, with the help of hospital dieticians. On 
arrival in the units, blood was taken for assessment 
of the hemoglobin, serum proteins, urea, electrolytes, 
and creatinine. Urine and fistula outputs were record. 
Treatment was started by administration of intravenous 
fluids and electrolytes. The fluid volume was replaced 
by addition of the recorded fluid losses and another 1.7 
liters for insensible loss. Particular attention was paid to 
nutritional support, which was given as high calorie-high 
protein diets orally. This was occasionally supplemented 
by enteric feeding via a nasogastric tube. These diets were 
prepared by the hospital dieticians, to ensure these patients 
got up to 3000 calories daily. There was no attempt at 
feeding the distal limb of the fistulas. These patients had 
daily enemas to ensure there was no distal obstruction by 
fecaloma. Pharmacological agents were not used to decrease 
fistula output.
Fistulography was the radiological investigation of choice, 
but some of the patients had barium enema. Abdominal 
ultrasonography was carried out especially when intra 
abdominal abscess was suspected. Sources of infection were 
identified and treated expeditiously, while intra-abdominal 
collections when present were explored and evacuated. 
Skin protection was achieved using zinc oxide paste and 
frequent wound dressings as needed daily; depending on 
the output of the fistula.
Surgical operations were undertaken for non-healing fistulas 
after a minimum period of 6 weeks of conservative therapy; 
once patients were found medically fit. Surgical treatment 
comprised laparotomy and resection of the bowel bearing 
the fistula, with end to end anastomosis.
Results
Of 82 patients comprising 40 males and 42 females studied, 
the median age was 31.7 years (range 13–68 years). Seventy-
two (87.8%) had hypoalbuminemia, as well as fluid and 
electrolyte imbalances, whereas 16 (19.5%) were anemic. 
The anemic patients got blood transfusion for correction of 
anemia. Intravenous infusion and adequate feeding corrected 
the fluid and electrolyte deficits and hypoalbuminemia 
in all but six patients who died before they could be 
stabilized. Most of the fistulas occurred in patients aged 
below 41 years- [Table 1], and the small bowel was most 
commonly affected [Table 2]. Majority of the fistulas resulted 
from surgical operations [Table 3] and fistulas secondary to 
appendicectomy, predominated, followed by operations for 
bowel obstruction and typhoid perforation. A few resulted 
from cesarean sections. These appendicectomy were 
performed by nonsurgical specialists in private practice. 
Sixteen patients had fistulas unrelated to surgical operations 
including induced abortion, hysterosalpingography, 
strangulated hernias, colonic carcinomas, and trauma 
[Table 2]. Although every patient was tried initially on non-
operative therapy, only 26 had spontaneous closure.
Fistula description and characteristics
There were 57 low output and 25 high output fistulas. 
The small intestine was the origin of fistula in 55 patients, 
that is, the jejunum accounted for 6, the ileum for 21, and 
unclassified small bowel for 28. The cecum was responsible 
in 14 and the colon in 13 patients. The most common cause 
of these fistulas was a recent abdominal operation especially 
appendicectomy, followed by operations for small bowel 
obstruction and closure of the ileum for typhoid perforation. 
Other causes are shown in Tables 3 and 4.
Operative treatment
Patients whose fistula did not closure after a minimum 
period of 6 weeks of conservative therapy were operated 
upon, provided they were fit. Fifty patients fell into this 
Table 1: Age distribution







Table 2: Origin of enterocutaneous fistulas




Table 3: Etiology of fistulas
Postoperative 66
Strangulated hernia 2
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category and they required operative resection for the 
fistula bearing segment and restorative anastomosis. This 
was successful in healing the fistula in (84%) 42 patients.
Mortality
Out of the 82 patients, 14 (17%) patients died. Thirteen 
had high output fistula, whereas one had the low output 
variety. Six of these died while on conservative therapy due 
to a combination of hypovolemia sepsis and multiorgan 
failure. The remaining eight had surgical operations; 
whereas one had a cardiac arrest and died 24 hours after 
operation, another died 24 days after operative treatment. 
They all died from a combination of peritonitis and 
multiorgan failure.
Discussion
Enterocutaneous fistula remains a challenging problem 
to manage. The results of 82 patients managed for 
enterocutaneous fistula over an 11 year period were 
analyzed. The fistulas were often complications of previous 
operations, many from private hospitals run by nonsurgical 
specialists. Others were caused by some form of trauma 
[Table 3] but there were a few spontaneous cases that 
resulted from strangulated inguinal hernias, and perforated 
colonic carcinomas. The dominant role of appendicectomy 
and private hospitals in the causation of enterocutaneous 
fistula noted in this study, had been recorded elsewhere in 
Nigeria.[8,9] Forty-two females and 40 males studied were 
afflicted by this disorder, and their ages ranged from 13 to 
68 years with a median age of 31.7 years. Majority of the 
patients were young people [Table 1] who generally belonged 
to the group that underwent many of the operations, which 
led to enterocutanous fistula.
During the period of non-operative therapy, 6 very ill 
patients died whereas 26 had spontaneous fistula closure. 
Consequently, 50 patients had elective surgical treatment 
for closure of their fistulas. During the period of conservative 
therapy, these patients received 3000 calories daily, as high 
calorie–high protein diet, because adequate nutritional 
support is recognized as a key factor in reducing the mortality 
rate in this disorder. This nutritional support was given 
by the enteral route. Enteral feeding has a trophic effect 
on the bowel and prevents mucosal atrophy. It also plays 
an important role in immune system preservation, while 
preventing the translocation of bacteria.[10]
Many workers in this field agree that immediate surgical 
correction of the fistula is usually not a treatment priority.[11] 
Apart from the time taken to ensure adequate nutrition, 
appropriate delay of at least 6 weeks is needed for resolution 
of the accompanying intra abdominal inflammation. The 
31.7% healing rate seen in those managed non-operatively, 
is in keeping with spontaneous closure rates reported in 
literature; which varies from 17% to 75%, depending on 
a number of factors.[12] These factors include the etiology, 
free distal flow, size of the enteral defect, healthy bowel, 
fistula output, associated co-morbidity, and epithelialization 
of the tract.[12,13] A review of the literature[14] suggests 
that, whereas spontaneous closure occurs in about 30% 
of patients with enterocutaneous fistulas; 90-95% of 
fistulas that spontaneously resolve do so within the first 
4-5 weeks. Therefore it is surgically unwise to operate 
within this period. The healing rate after definitive 
operation in this study was 84% (42 patients), and for 
the entire group of 82 patients the overall fistula healing 
rate was 82.9%. This compares favorably with findings of 
Draus et al.[1] and Taggarshe et al.,[15] who recorded healing 
rates of 82% and 85%, respectively, after using total 
parenteral nutrition, octreotide, fibrin glue, and VAC to 
treat fistulas of diverse etiologies, including inflammatory 
bowel diseases and radiotherapy. Octreotide a synthetic 
analogue of somatostatin, inhibits gastro-intestinal, and 
pancreatic secretions. It should therefore decrease fistula 
output and lead to spontaneous closure. It also inhibits gall 
bladder contractility and motility. Gall bladder sludge or 
asymptomatic gallstones occur in 20-50% of patients treated 
with synthetic analogues of somatostatin.[16] Thus, although 
this hormone may reduce fistula output, simplifying care of 
these patients, routine use is controversial.[14,17]
Fourteen patients (17%) in this study, died and this is within 
the quoted mortality rate of 5-20%.[1,2]
Early institution and correction of fluid and electrolyte 
imbalances, nutritional support, control of sepsis and 
correctly timed surgical therapy, resulted in this good healing 
rate and acceptable mortality which is within the quoted 
rate in literature.[6,7] The absence of facilities which reduce 
fistula flow and, total parenteral nutrition, biologic fibrin 
glue injection or wound VAC should not deter surgeons 
in developing countries from treating these patients, and 
getting results comparable to what is found in literature. 
A major challenge is how to eradicate postappendicectomy 
fistulas, which accounted for 33 of the cases (40.2%). One 
option is to suggest that nonsurgical specialists should not 
perform any surgical operation. This is the stand of the 
National Health Insurance scheme presently, as it does not 
pay general practitioners fees for surgical operations, no 
matter how minor, because they are only allowed to register 
as primary care providers The scheme only pays qualified 
and registered. surgeons for surgical operations, because 
they register as secondary care providers.[18] This option 
Table 4: Operations
Closure of typhoid perforation 10
Caesarean section 2
Operations for intestinal obstruction 10
Appendicectomy 33
Colectomy for cancer 4
Total 66
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may increase the difficulties of sick patients in search of 
surgical treatment on emergency basis. Therefore, another 
suggested option is for Nigerian medical and dental council 
to instruct non-specialist (surgical) private practitioners to 
get hands on training in operations for common surgical 
disease, as part of their continuing medical education. This 
step will in all probability eradicate post-appendicectomy 
enterocutaneous fistulas.
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